Comparative effectiveness of dupilumab and omalizumab on asthma exacerbations and systemic corticosteroid prescriptions: Real-world US ADVANTAGE study
Open Access
- 24 August 2024
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 154 (6) , 1500-1510
Abstract
No abstract availableKeywords
Funding Information
- Regeneron Pharmaceuticals Inc
- Sanofi Genzyme
This publication has 21 references indexed in Scilit:
- Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulationJournal of Allergy and Clinical Immunology, 2023
- Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness GroupWorld Allergy Organization Journal, 2022
- Biologic use and outcomes among adults with severe asthma treated by US subspecialistsAnnals of Allergy, Asthma & Immunology, 2022
- Tezepelumab compared with other biologics for the treatment of severe asthma: a systematic review and indirect treatment comparisonJournal of Medical Economics, 2022
- Urgent need for pragmatic trial platforms in severe asthmaThe Lancet Respiratory Medicine, 2018
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled AsthmaNew England Journal of Medicine, 2018
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trialThe Lancet, 2016
- Dupilumab in Persistent Asthma with Elevated Eosinophil LevelsNew England Journal of Medicine, 2013
- The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studiesStatistics in Medicine, 2010
- Inhibition of the IL-4/IL-13 receptor system prevents allergic sensitization without affecting established allergy in a mouse model for allergic asthmaJournal of Allergy and Clinical Immunology, 2003